Global EditionASIA 中文双语Français
Home / Business / Companies

BGI Genomics backs colorectal cancer screening project in Beijing

By ZHENG YIRAN | | Updated: 2023-05-26 09:50
Share - WeChat
Liang Wenmei, executive deputy secretary general of the Western Returned Scholars Foundation (middle), donates 1,000 units of colorectal cancer screening materials to the community healthcare center in Beiqijia, Beijing. [Photo provided to]

Shenzhen, Guangdong province-based genomic sequencing company BGI Genomics supported a public welfare colorectal cancer screening project in Beijing, in an effort to deliver advanced screening technology to communities.

The project, launched by the Western Returned Scholars Foundation, offers free screening services to a lot of communities in Beijing. So far, 22 screening stations have been established. A total of 4,733 samples have been collected, from which 4,312 report have come out.

According to the results, the positive rate of colorectal cancer has been increasing significantly after the age of 45, consistent with the trend of colorectal cancer incidence in China.

Healthcare professionals from communities in Beijing said the public welfare project will promote the standardization and long-term development of colorectal cancer screening in communities.

Li Haiju, secretary general of the Western Returned Scholars Foundation, said: "The public welfare project is a more precise and effective prevention of colorectal cancer. It moves the prevention measures ahead, and serves as an innovation of prevention and treatment coordination mechanism. It improves the early monitoring and rapid screening capabilities at grass-root level, controlling major diseases from the very beginning."

She noted that one of the advantages of the public welfare project is that it adopts non-invasive self-sampling. Another advantage is that the screening technique contains high throughput and high sensitivity. Also, as the project is community-based, it offers more convenience to people.

Li Jie, senior sales director of BGI Genomics, said: "The progression from precancerous lesions to cancer usually takes 10 to 15 years. This is an important time window for early diagnosis and clinical intervention of cancer. Therefore, the key to reducing the incidence rate of colorectal cancer and improving the survival rate is to actively carry out high-risk population screening, and find precancerous lesions and early cancer patients."

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349